Algert Global LLC Has $2.37 Million Stake in Oscar Health, Inc. (NYSE:OSCR)

Algert Global LLC cut its holdings in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 52.3% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 176,296 shares of the company's stock after selling 193,389 shares during the quarter. Algert Global LLC owned 0.07% of Oscar Health worth $2,369,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. Vanguard Group Inc. raised its stake in shares of Oscar Health by 3.2% during the 4th quarter. Vanguard Group Inc. now owns 18,997,973 shares of the company's stock worth $255,333,000 after purchasing an additional 586,626 shares in the last quarter. JPMorgan Chase & Co. lifted its stake in Oscar Health by 348.7% in the fourth quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company's stock valued at $139,246,000 after acquiring an additional 8,051,379 shares during the last quarter. Gilder Gagnon Howe & Co. LLC lifted its stake in Oscar Health by 51.4% in the fourth quarter. Gilder Gagnon Howe & Co. LLC now owns 6,335,862 shares of the company's stock valued at $85,154,000 after acquiring an additional 2,151,256 shares during the last quarter. BIT Capital GmbH increased its stake in shares of Oscar Health by 5,711.6% during the 4th quarter. BIT Capital GmbH now owns 4,473,853 shares of the company's stock worth $60,129,000 after purchasing an additional 4,396,872 shares during the last quarter. Finally, Geode Capital Management LLC increased its stake in shares of Oscar Health by 3.0% during the 4th quarter. Geode Capital Management LLC now owns 4,468,098 shares of the company's stock worth $60,065,000 after purchasing an additional 128,458 shares during the last quarter. Institutional investors and hedge funds own 75.70% of the company's stock.

Wall Street Analyst Weigh In

Separately, Wells Fargo & Company cut shares of Oscar Health from an "overweight" rating to an "equal weight" rating and decreased their price objective for the stock from $20.00 to $16.00 in a report on Thursday, March 13th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $20.08.

Oscar Health Stock Performance

Shares of NYSE OSCR traded up $0.05 during trading hours on Friday, hitting $17.11. 12,689,608 shares of the stock were exchanged, compared to its average volume of 4,069,818. The firm has a market capitalization of $4.29 billion, a P/E ratio of -855.07 and a beta of 1.75. Oscar Health, Inc. has a one year low of $11.20 and a one year high of $23.79. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. The company's 50 day moving average is $13.34 and its 200 day moving average is $14.61.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The company reported $0.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.83 by $0.09. The company had revenue of $3 billion for the quarter, compared to the consensus estimate of $2.87 billion. Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. The firm's revenue was up 42.2% compared to the same quarter last year. During the same period last year, the business posted $0.62 earnings per share. On average, research analysts expect that Oscar Health, Inc. will post 0.69 EPS for the current year.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.